Decades of hard-won progress in HIV mortality and incidence reduction may be unraveling — and for women in particular, the reasons extend well beyond viral biology into the social structures that govern intimate relationships. Understanding precisely how much of the global HIV burden originates in intimate partner violence, and what funding withdrawals mean quantitatively for antiretroviral access, reframes HIV prevention as inseparable from gender equity and sustained financial commitment.
Drawing on the Global Burden of Disease 2023 framework — covering 204 countries and territories with annual estimates from 1990 through 2023 — investigators modeled HIV incidence, prevalence, and mortality disaggregated by age and sex. A key methodological advance was the integration of time-series IPV prevalence estimates with effect-size data to calculate population attributable fractions, isolating the share of HIV burden causally linked to intimate partner violence among women. Separately, a non-parametric stochastic frontier model projected how reductions in development assistance for health would ripple through antiretroviral treatment coverage and downstream mortality trajectories through 2030. The dual analytical architecture — retrospective burden attribution combined with prospective funding-shock modeling — gives this analysis unusual translational weight.
This work arrives at a pivotal inflection point in global health financing. Existing evidence already established IPV as a biological and behavioral risk amplifier for HIV acquisition in women — through coercive sex, constrained healthcare access, and impaired medication adherence — but quantifying its population-attributable fraction at national resolution is methodologically novel and policy-relevant. The funding-cut forecasting component is particularly sobering given recent real-world reductions in U.S. PEPFAR allocations and Global Fund contributions. Limitations inherent to GBD analyses include reliance on heterogeneous national surveillance data of variable quality and the challenge of isolating IPV causality in observational frameworks. Still, as a large-scale synthesis spanning 33 years and 204 territories, this is not an incremental update — it offers a structural argument that gender-based violence reduction and stable HIV financing are not peripheral concerns but central determinants of epidemic trajectory through 2030.